New Product Planning
Incyte
July 01, 2026
Remote friendly (Chadds Ford, PA)
United States
Marketing
Core Responsibilities
- Product Planning: Co-develop Target Product Profiles (TPPs); provide US commercial input to trial design/evidence generation, regulatory/labeling strategy, and differentiation vs. standard of care; translate scientific/clinical data into commercial implications, risks, and opportunities; support assets from preclinical through Phase II/III decision points.
- Market Shaping: Understand disease biology/paradigm, patient segmentation/unmet need, and competitive pipeline; lead market-shaping strategies (disease awareness, diagnostic pathway evolution, KOL engagement, scientific leadership positioning, early value proposition/positioning); generate insights via primary research, competitive intelligence, and analog analysis; anticipate market dynamics and access environment (pricing, reimbursement, guidelines).
- Shape portfolio & investment decisions: Lead US commercial assessments (market sizing/epidemiology/patient flow, forecasting/valuation, scenario planning/risk); support governance forums (portfolio prioritization, stage-gate decisions, BD/licensing evaluations); recommend where to invest vs. deprioritize.
- Organizational Readiness: Drive cross-functional alignment (R&D, Medical, Market Access, Regulatory, Commercial); build early brand strategy and launch blueprint (positioning, value story, evidence plan, go-to-market hypotheses); define required future capabilities (field model, diagnostics, patient identification, payer engagement); establish a 2–5 year pre-launch roadmap and milestones.
- Cross-functional & external leadership: Serve as US commercial lead on global asset teams; influence senior stakeholders without direct authority; engage external stakeholders (KOLs, investigators, scientific societies); operate as a matrix leader across geographies/functions.
Qualifications
- Education: Bachelor’s degree required; MBA or advanced degree preferred (PharmD, MBA).
- Experience: 8–12+ years in pharma/biotech; experience in one or more: New Product Planning, Clinical Development, Oncology Marketing/Market Access, Medical Affairs.
- Key Skills & Capabilities: Strategic thinking (science → market → value), oncology expertise, immunology experience, clinical-commercial integration, market shaping mindset, advanced analytics (forecasting/valuation/scenario modeling), influence without authority, strong communication.
- Product Planning: Co-develop Target Product Profiles (TPPs); provide US commercial input to trial design/evidence generation, regulatory/labeling strategy, and differentiation vs. standard of care; translate scientific/clinical data into commercial implications, risks, and opportunities; support assets from preclinical through Phase II/III decision points.
- Market Shaping: Understand disease biology/paradigm, patient segmentation/unmet need, and competitive pipeline; lead market-shaping strategies (disease awareness, diagnostic pathway evolution, KOL engagement, scientific leadership positioning, early value proposition/positioning); generate insights via primary research, competitive intelligence, and analog analysis; anticipate market dynamics and access environment (pricing, reimbursement, guidelines).
- Shape portfolio & investment decisions: Lead US commercial assessments (market sizing/epidemiology/patient flow, forecasting/valuation, scenario planning/risk); support governance forums (portfolio prioritization, stage-gate decisions, BD/licensing evaluations); recommend where to invest vs. deprioritize.
- Organizational Readiness: Drive cross-functional alignment (R&D, Medical, Market Access, Regulatory, Commercial); build early brand strategy and launch blueprint (positioning, value story, evidence plan, go-to-market hypotheses); define required future capabilities (field model, diagnostics, patient identification, payer engagement); establish a 2–5 year pre-launch roadmap and milestones.
- Cross-functional & external leadership: Serve as US commercial lead on global asset teams; influence senior stakeholders without direct authority; engage external stakeholders (KOLs, investigators, scientific societies); operate as a matrix leader across geographies/functions.
Qualifications
- Education: Bachelor’s degree required; MBA or advanced degree preferred (PharmD, MBA).
- Experience: 8–12+ years in pharma/biotech; experience in one or more: New Product Planning, Clinical Development, Oncology Marketing/Market Access, Medical Affairs.
- Key Skills & Capabilities: Strategic thinking (science → market → value), oncology expertise, immunology experience, clinical-commercial integration, market shaping mindset, advanced analytics (forecasting/valuation/scenario modeling), influence without authority, strong communication.